Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Role of Skin in Vitamin D Synthesis

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Toxin of the Year.

Dermatitis : contact, atopic, occupational, drug·2026

Same author

Editors and Journals: Part III-"<i>Sto Tavo</i> (Who Is In Charge)?"

Skinmed·2024

Same author

Remission of Refractory PASH Syndrome Using Ixekizumab and Doxycycline

Journal of drugs in dermatology : JDD·2020

Same author

The bicycle wheel analogy for linear closures of small suborbital cheek defects.

Dermatology online journal·2020

Same author

Painful cutaneous lesions on the extremities.

Journal of the American Academy of Dermatology·2019

Same author

Long-term sheltering mustaches reduce incidence of lower lip actinic keratosis.

Journal of the American Academy of Dermatology·2018

Search research articles

Related Experiment Videos

Psoriasis: can statins play a dual role?

Anand N Rajpara¹, Ronald Goldner, Anthony Gaspari

¹School of Medicine, University of Maryland, Baltimore, Maryland, USA. arajpara@gmail.com

Dermatology Online Journal

|February 25, 2010

Summary

Psoriasis patients face higher risks of atherosclerosis and coronary artery disease (CAD). Statins, used for hyperlipidemia, may also reduce psoriasis inflammation and disease activity.

Area of Science:

Dermatology
Cardiology
Immunology

Background:

Psoriasis is linked to increased atherosclerosis, including coronary artery disease (CAD).
Inflammation is a key factor in both psoriasis and atherosclerosis.
Psoriatic patients have a higher risk of CAD and myocardial infarction (MI).

Purpose of the Study:

To explore the potential dual role of statins in managing psoriasis and its associated cardiovascular risks.
To investigate if statins can lower lipid levels and reduce psoriatic disease activity.

Main Methods:

Review of existing literature on psoriasis, atherosclerosis, and statin mechanisms.
Analysis of hyperlipidemia as a modifiable risk factor in psoriatic patients.
Consideration of statins' lipid-lowering and anti-inflammatory properties.

Related Experiment Videos

Main Results:

Hyperlipidemia is a manageable risk factor in psoriasis patients.
Statins are effective in preventing CAD and MI in hyperlipidemic individuals.
Statins possess anti-inflammatory and immunomodulatory effects potentially beneficial for psoriasis.

Conclusions:

Statins may offer a dual benefit for psoriasis patients by addressing hyperlipidemia and reducing disease activity.
Further investigation into statins' efficacy for psoriatic inflammation is warranted.
Statins represent a safe, cost-effective option for managing cardiovascular risk in psoriasis.